Effect of flunixin meglumine on cytokine levels in experimental endotoxemia in mice

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 54, Issue 7, 2007, Pages 352-355

  Yazar, E ^a   Er, A ^a   Uney, K ^a   Altunok, V ^a   Elmas, M ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIXIN; CYTOKINE; DRUG DERIVATIVE; FLUNIXIN MEGLUMINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; ENDOTOXEMIA; MALE; MOUSE; PATHOLOGY; RANDOMIZATION;

ANIMALS; CLONIXIN; CYTOKINES; ENDOTOXEMIA; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED BALB C; PROSTAGLANDIN ANTAGONISTS; RANDOM ALLOCATION; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; ESCHERICHIA COLI; MUS;

EID: 34548129946     PISSN: 0931184X     EISSN: 14390442     Source Type: Journal    
DOI: 10.1111/j.1439-0442.2007.00959.x     Document Type: Article

References (26)

1. Allen, D.G., J.K. Pringle, D.A. Smith W.B. Pasloske, 1998 : Handbook of Veterinary Drugs, Lippincott Raven, New York.
2. Anderson, K. L., A. R. Smith, R. D. Shanks, L. E. Davis B. K. Gustafsson, 1986 : Efficacy of flunixin meglumine for the treatment on endotoxin-induced bovine mastitis. Am. J. Vet. Res. 47, 1366 1372.
3. Baskett, A., M. H. Barton, N. Norton, B. Anders J.N. Moore, 1997 : Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. Am. J. Vet. Res. 58, 1291 1299.
4. Boothe, D. M., 2001 : The analgesic, antipyretic, anti-inflammatory drugs. In : Adams, H. R. (ed. Veterinary Pharmacology and Therapeutics. pp. 433 451. Iowa State Press, Ames, IA.
5. Coimbra, R., H. Melbostad, W. Loomis, M. Tobar D. B. Hoyt, 2005 : Phosphodiesterase inhibition decreases nuclear factor-kB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia. J. Trauma 59, 575 582.
6. Dogan, M. D., H. Ataoglu E. S. Akarsu, 2002 : Nimesulide and diclofenac inhibit lipopolysaccharide induced hypodermia and tumour necrosis factor- α elevation in rats. Fudam. Clin. Pharmacol. 16, 303 309.
7. Elmas, M., E. Yazar, K. Uney A. Karabacak, 2006 : Pharmacokinetics of flunixin after intravenous administration in healthy and endotoxaemic rabbits. Vet. Res. Commun. 30, 73 81.
8. Fukuda, T., H. Sumichika, M. Murata, T. Hanano, K. Adachi M. Hisadome, 2000 : A novel regulator tumor necropsies factor-α and interleukin-10 protects mice from endotoxin-induced shock. Eur. J. Pharmacol. 391, 317 320.
9. Goetz, F. W., J. V. Planas S. Mackenzie, 2004 : Tumor necrosis factor. Dev. Comp. Immunol. 28, 487 497.
10. Gourine, A.V., L. R. Leon, K. Rudolph, J. Tesfaigzi M. J. Kluger, 2000 : Cytokine cascade induced by endotoxin in TNF double receptor knockout mice: evidence supporting a role for IL-10 in mediating antipyretic action of TNF. J. Therm. Biol. 25, 21 27.
11. Gouvy, M., S. Struyf, P. Proost J. van Damme, 2005 : Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth F. R. 16, 561 580.
12. van Gucht, S., G. Labarque K. V. Reeth, 2004 : The combination of PRRS virus and bacterial endotoxin as a model for multifactorial respiratory disease in pigs. Vet. Immunol. Immunopathol. 102, 165 178.
13. Hartel, C., J. von Puttkamer, F. Gallner, T. Strunk C. Schultz, 2004 : Dose dependent immunomudulatory effect of acetylsalicylic acid and indometacin in human whole blood: potential role of cyclooxygenase-2 inhibition. Scan. J. Immunol. 60, 412 420.
14. Hawk, C.T. S.L. Leary, 1999 : Formulary for Laboratory Animals, 2nd edn, Iowa State University Press, Ames, IA.
15. Hewet, J. A. R. A. Roth, 1993 : Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol. Rev. 45, 381 411.
16. Jackman, B.R., J.N. Moore, M.H. Barton D.D. Morris, 1994 : Comparison of the effects of ketoprofen and flunixin meglumine on the in vitro response of equine peripheral blood monocytes to bacterial endotoxin. Can. J. Vet. Res. 58, 138 143.
17. Kaiser, P., L. Rothwell, S. Avery S. Balu, 2004 : Evaluation of the interleukins. Dev. Comp. Immunol. 28, 375 394.
18. Lee, J.I. G.J. Burckart, 1998 : Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol. 38, 981 993.
19. Lin, H., S. J. Chu, D. Wang N. H. Feng, 2004 : Pharmacological modulation of TNF production in macrophages. J. Microbiol. Immunol. Infect. 37, 8 15.
20. Marshall, M. P. K. Moore, 2004 : Effect of nitric oxide releasing paracetamol and flurbibrofen on cytokine production in human blood. Eur. J. Pharmacol. 483, 317 322.
21. Mayeux, P. R., 1997 : Pathobiology of lipopolysaccharide. J. Toxicol. Environ. Health 51, 415 435.
22. Redl, H., A. Spittler W. Strohmaier, 2002 : Markers of sepsis. In : Vincent, J.L., J. Carlet S. M. Opal (eds The Sepsis Text. pp. 47 67. Kluwer Academic Publisher, New York.
23. Stuhlmeier, K.M., H. Li J.J. Kao, 1999 : Ibuprofen: New explanation for and old phenomenon. Biochem. Pharmacol. 57, 313 320.
24. Vittimberga, F.J., T. P. McDade, R. A. Perugini P. Callery, 1999 : Sodium salicylate inhibits macrophage TNFα production and alters MAPK activation. J. Surg. Res. 84, 143 149.
25. Yazar, E., R. Col, S. Konyalioglu, Y. O. Birdane, M. Elmas A. L. Bas, 2004 : Effect of vitamin E and prednisolone on biochemical and haematological parameters in endotoxaemic New Zealand white rabbits. Bull. Vet. Inst. Pulawy 48, 105 108.
26. Zalewska-Kaszubska, J. D. Gorska, 2001 : Anti-inflammatory capabilities of macrolides. Pharmacol. Res. 44, 451 454.